TY  - JOUR

T1  - Abaloparatide: an anabolic treatment to reduce fracture risk in postmenopausal women with osteoporosis

JO  - Current Medical Research and Opinion

UR  - https://eprints.whiterose.ac.uk/167052/

PY  - 2020/10/12

AU  - Miller PD

AU  - Bilezikian JP

AU  - Fitzpatrick LA

AU  - Mitlak B

AU  - McCloskey EV

AU  - Cosman F

AU  - Bone HG

ED  - 

DO  - DOI: 10.1080/03007995.2020.1824897

PB  - Informa UK Limited

Y2  - 2024/12/22

ER  -